PEDONE, CLAUDIO
 Distribuzione geografica
Continente #
AS - Asia 11.066
NA - Nord America 5.365
EU - Europa 2.194
SA - Sud America 763
AF - Africa 129
Continente sconosciuto - Info sul continente non disponibili 90
OC - Oceania 43
Totale 19.650
Nazione #
SG - Singapore 7.327
US - Stati Uniti d'America 5.139
CN - Cina 1.578
HK - Hong Kong 1.198
IT - Italia 1.003
BR - Brasile 557
GB - Regno Unito 401
VN - Vietnam 330
FR - Francia 293
BD - Bangladesh 185
DE - Germania 136
IN - India 136
CA - Canada 122
AR - Argentina 77
NL - Olanda 55
ID - Indonesia 54
MX - Messico 54
ZA - Sudafrica 46
ES - Italia 42
PL - Polonia 40
AU - Australia 39
TR - Turchia 37
EC - Ecuador 36
UA - Ucraina 34
FI - Finlandia 33
JP - Giappone 29
IQ - Iraq 28
CO - Colombia 23
PK - Pakistan 23
IR - Iran 19
PH - Filippine 19
SA - Arabia Saudita 19
MA - Marocco 17
CL - Cile 16
RU - Federazione Russa 16
VE - Venezuela 16
LT - Lituania 15
SE - Svezia 15
CZ - Repubblica Ceca 13
TN - Tunisia 12
BG - Bulgaria 11
MD - Moldavia 11
PY - Paraguay 11
RS - Serbia 11
NP - Nepal 10
PE - Perù 10
UY - Uruguay 10
CR - Costa Rica 9
EG - Egitto 9
KE - Kenya 8
KZ - Kazakistan 8
IL - Israele 7
JM - Giamaica 7
MY - Malesia 7
AT - Austria 6
BE - Belgio 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
IE - Irlanda 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
DZ - Algeria 5
EE - Estonia 5
TH - Thailandia 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
HN - Honduras 4
KR - Corea 4
NI - Nicaragua 4
PT - Portogallo 4
RO - Romania 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
DK - Danimarca 3
JO - Giordania 3
KH - Cambogia 3
KY - Cayman, isole 3
LU - Lussemburgo 3
MK - Macedonia 3
PA - Panama 3
PR - Porto Rico 3
SN - Senegal 3
TJ - Tagikistan 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BH - Bahrain 2
BY - Bielorussia 2
CH - Svizzera 2
CM - Camerun 2
GE - Georgia 2
HU - Ungheria 2
LB - Libano 2
LY - Libia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
QA - Qatar 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
Totale 19.522
Città #
San Jose 1.702
Hong Kong 1.194
Ashburn 1.113
Singapore 1.081
Rome 718
Hefei 596
Boardman 347
London 345
Beijing 263
Lauterbourg 246
Shanghai 207
Dallas 193
Santa Clara 118
Ho Chi Minh City 111
Los Angeles 86
New York 80
Hanoi 78
Council Bluffs 75
San Francisco 69
São Paulo 51
Munich 47
Pune 42
Toronto 37
Washington 37
Seattle 34
Warsaw 30
Brooklyn 29
Mexico City 29
Orem 28
Milan 27
Amsterdam 26
West Jordan 26
Rio de Janeiro 25
Chicago 24
Montreal 24
Atlanta 22
Boston 22
Turku 21
Da Nang 19
Haiphong 19
Johannesburg 19
Tokyo 19
Buffalo 18
Guangzhou 18
Canberra 17
Chennai 16
Biên Hòa 15
Guayaquil 14
Frankfurt am Main 13
Las Vegas 13
Manchester 13
Paris 13
Phoenix 13
Charlotte 12
Melbourne 12
Quito 12
Helsinki 11
Houston 11
Baghdad 10
Calgary 10
Lahore 10
Porto Alegre 10
Stockholm 10
Ankara 9
Bari 9
Dhaka 9
Montevideo 9
Mumbai 9
Riyadh 9
Salvador 9
Shenzhen 9
Zhengzhou 9
Belgrade 8
Belo Horizonte 8
Bologna 8
Brno 8
Florence 8
Markham 8
Bogotá 7
Caracas 7
Lima 7
Madrid 7
Nairobi 7
Nuremberg 7
San José 7
Bình Dương 6
Curitiba 6
Guarulhos 6
Jakarta 6
Manaus 6
Memphis 6
Naples 6
Osasco 6
Ribeirão Preto 6
Sydney 6
Turin 6
Ahmedabad 5
Asunción 5
Bauru 5
Brasília 5
Totale 9.814
Nome #
Is Citicoline Effective in Preventing and Slowing Down Dementia?—A Systematic Review and a Meta-Analysis 511
A decision support system for tele-monitoring copd-related worrisome events 269
A Novel Interplay Between Irisin and PTH: From Basic Studies to Clinical Evidence in Hyperparathyroidism 262
Age-Related Changes in Clinical Presentation of Covid-19: the EPICOVID19 Web-Based Survey 237
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 229
Migrants rescued on the Mediterranean Sea route: nutritional, psychological status and infectious disease control 228
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 226
Bone Quality as Measured by Trabecular Bone Score in Normocalcemic Primary Hyperparathyroidism 225
Agreement between equations estimating glomerular filtration rate in elderly nursing home residents and in hospitalised patients: implications for drug dosing 218
Alternative ways of expressing FEV1 and mortality in elderly people with and without COPD 215
ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study 214
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 213
Sclerostin regulation, microarchitecture, and advanced glycation end-products in the bone of elderly women with type 2 diabetes 211
Computed tomography highlights increased visceral adiposity associated with critical illness in covid-19 210
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths 206
A rare cause of chronic diarrhoea in an elderly patient 200
Asthma in the elderly: mortality rate and associated risk factors for mortality 183
Treating COPD in Older and oldest old Patientsp 181
Predictors of undernutrition in COPD patients 180
Relationship between FEV1 and arterial stiffness in elderly people with chronic obstructive pulmonary disease 175
Non-invasive ventilation in octuagenarians out of the intensive care unit: Tolerability, efficacy and safety results 172
"Cardiovascular dementia" reappraisal of an old concept and Giambattista Vico's course and recourse theory: is history repeating itself? 157
25(OH) vitamin D and functional outcomes in older adults admitted to rehabilitation units: the safari study 154
Accuracy of spirometry in diagnosing pulmonary restriction in elderly people 150
CLINICAL, BIOCHEMICAL AND RADIOLOGICAL PROFILE OF NORMOCALCAEMIC HYPERPARATHYROIDISM: A MULTICENTRIC CROSS-SECTIONAL EVALUATION 149
Detecting Dementia by Saliva Analysis: A Fingerprinting Unobtrusive Method Based on a Fast and Cheap Sensor System 146
Increased carotid thickness in subjects with recently-diagnosed diabetes from rural Cameroon 145
Ageing and COPD affect different domains of nutritional status: the ECCE study 142
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 138
Accessibility to SARS-CoV-2 swab test during the Covid-19 pandemic: Did age make the difference? 138
An extra virgin olive oil-enriched chocolate spread positively modulates insulin-resistance markers compared with a palm oil-enriched one in healthy young adults: A double-blind, cross-over, randomised controlled trial 134
Association of reduced total lung capacity with mortality and use of health services 133
CARDIOVASCULAR AUTONOMIC NEUROPATHY CAUSES AN IMPAIRMENT OF QUALITY OF LIFE IN SUBJECTS WITH CHRONIC HYPOPARATHYROIDISM 130
BIONOTE e-nose technology may reduce false positives in lung cancer screening programmes 129
Agreement between Chronic Kidney Disease Epidemiological Collaboration and Berlin Initiative Study equations for estimating glomerular filtration rate in older people: The Invecchiare in Chianti (Aging in Chianti Region) study 127
BODE index or geriatric multidimensional assessment for the prediction of very-long-term mortality in elderly patients with chronic obstructive pulmonary disease? A prospective cohort study 127
Alternative ways of expressing forced expiratory volume in the first second and long-term mortality in elderly patients with asthma 123
Age does not hamper the response to pulmonary rehabilitation of COPD patients 121
Adiponectin and bone mass density The InCHIANTI study 121
Vertebral fractures and mortality risk in hospitalised patients during the COVID-19 pandemic emergency 120
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 120
Clinical, biochemical, and radiological profile of normocalcemic primary hyperparathyroidism 117
The Oxygen therapy 116
Authors' Reply to Brunetti et al. "Potentially Inappropriate Medications, Drug-Drug Interactions, and Anticholinergic Burden in Elderly Hospitalized Patients: Does an Association Exist with Post-Discharge Health Outcomes?" 116
Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA) 114
Effects of different masks on diaphragm motion in OSAS patients undergoing CPAP: results from an ultrasound-based proof of concept study 109
Cardiovascular autonomic neuropathy as a cause of fatigue in chronic hypoparathyroidism 109
Analysis of volatile organic compounds: an innovative approach to heart failure characterization in older patients 107
Pre-polysomnographic assessment using the Pittsburgh Sleep Quality Index questionnaire is not useful in identifying people at higher risk for obstructive sleep apnea 107
Cardiovascular Autonomic Neuropathy as a New Complication of Postsurgical Chronic Hypoparathyroidism 105
Association between frailty index, lung function, and major clinical determinants in chronic obstructive pulmonary disease 104
Genetic background of idiopathic pulmonary fibrosis 103
Risk Factors for Fragility Fractures in Type 1 Diabetes 101
Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher advanced glycation end-products (AGEs) content and reduced bone strength 100
Noninvasive ventilation in older adults admitted to a pneumogeriatric unit 98
Use of Plant-Derived Natural Products in Sleep Disturbances 97
Is it time to use pre-bronchodilator spirometry to rule out COPD? 95
Energy expenditure and intake in COPD: The extent of unnoticed unbalance by predicting REE 93
Dementia, osteoporosis and fragility fractures: Intricate epidemiological relationships, plausible biological connections, and twisted clinical practices 92
Patients with migraine with aura have increased flow mediated dilation 90
Age and severe adverse drug reactions caused by nifedipine and verapamil. Gruppo Italiano di Farmacovigilanza nell' Anziano (GIFA) 88
Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions 87
Utility of an electronic nose in discriminating obstructive sleep apnea and COPD by breath fingerprints analysis 68
Curcumin use in pulmonary diseases: State of the art and future perspectives 67
Efficacy of multiparametric telemonitoring on respiratory outcomes in elderly people with COPD: a randomized controlled trial 65
Association between PUFA intake and serum concentration and mortality in older adults: A cohort study 65
Nursing student attitudes towards older people: validity and reliability of the Italian version of the Kogan Attitudes towards Older People scale 64
Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? 64
PTH(1-34) for surgical hypoparathyroidism: A 2-year prospective, open-label investigation of efficacy and quality of life 63
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population 62
PTH(1-34) for the primary prevention of postthyroidectomy hypocalcemia: The THYPOS trial 62
Validation of FEV6 in the elderly: correlates of performance and repeatability 62
Incidence and Outcome of Pneumomediastinum in Non-ICU Hospitalized COVID-19 Patients 62
Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey 61
Effect of insulin resistance on BMD and fracture risk in older adults 61
On the remote detection of COPD-related worrisome events 60
Integration of voltammetric analysis, protein electrophoresis and pH measurement for diagnosis of pleural effusions: a non-conventional diagnostic approach 60
Non-invasive monitoring of lower-limb ulcers via exudate fingerprinting using BIONOTE 60
Correction: Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey 59
Chronic renal failure: a neglected comorbidity of COPD 58
Comorbidity modulates non invasive ventilation-induced changes in breath print of obstructive sleep apnea syndrome patients 58
Hemoglobin concentration influences N-terminal Pro B-type natriuretic peptide levels in hospitalized older adults with and without heart failure 58
Cardiac amyloidosis awareness among residents/specialists in geriatrics: An italian national survey 57
Chronic obstructive pulmonary disease in the elderly 57
Clusters of functional domains to identify older persons at risk of disability 57
Body mass index and mortality among hospitalized patients 57
GOLD and the fixed ratio Response 57
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 57
Correlates of mortality in elderly COPD patients: focus on health related quality of life 57
Association between sodium excretion and cardiovascular disease and mortality in the elderly: a cohort study 57
Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules: 12-Month Results of a Randomized Trial (LARA II Study) 57
Health status in older hospitalized patients with cancer or non-neoplastic chronic diseases 56
Quality of diet and potential renal acid load as risk factors for reduced bone density in elderly women 55
Effects of topical therapy on the breath pattern of patients with newly diagnosed COPD: An e-nose based study 55
Nutritional status is associated with physical function and disability in older adults with chronic heart failure 55
Are Performance Measures Necessary to Predict Loss of Independence in Elderly People? 55
Impact of Low Muscle Mass and Low Muscle Strength According to EWGSOP2 and EWGSOP1 in Community-Dwelling Older People 54
Gas exchanges and pulmonary vascular abnormalities at different stages of chronic liver disease 54
Systematic review of telemonitoring in COPD: an update 54
Restrictive pulmonary dysfunction at spirometry and mortality in the elderly. 54
Totale 11.861
Categoria #
all - tutte 148.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.610


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022378 0 5 17 0 10 1 2 9 12 8 5 309
2022/2023147 15 5 3 7 7 7 15 5 5 3 75 0
2023/20241.074 45 127 36 83 111 455 11 51 37 37 44 37
2024/20258.654 150 101 385 55 79 237 132 46 815 742 2.667 3.245
2025/20268.987 853 341 514 1.027 343 541 2.383 730 745 778 354 378
2026/2027410 410 0 0 0 0 0 0 0 0 0 0 0
Totale 19.650